The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
You may not be thinking about your cup of tea as you go over your pre-op plan with your health care provider. While herbal teas are natural, some can interact with medications and affect blood clotting, blood pressure and post-op healing. Jimmy Sung, M.D., shares, “The main reason we ask patients to stop all herbal supplements, including herbal tea, prior to surgery is to decrease the risk of bleeding and bruising. This is because many herbs have anticoagulant properties.”
That doesn’t mean you have to avoid all herbal teas. But, if you’re having surgery, there are some that should definitely be on your radar. “Most of the time, eating the real food or occasionally drinking a tea made with an herb would not result in a high-enough dose to affect a surgery,” says May Tom, RD. “It’s always better safe than sorry.”
So, which herbal teas might you want to avoid before and after surgery? To find out, we talked to doctors and dietitians. Here’s what they told us.
Ginger is known for helping with nausea and immunity. Tom notes, “It is popular during cold and flu season because it boosts the immune system, but it also can increase clotting time, so [it’s] best to avoid [it] for at least a week before surgery.” To date, few studies have actually shown that high doses of ginger slow blood clotting. So, more research is needed to confirm the extent of its effects. In the meantime, be sure to let your health care provider know if you are drinking ginger tea or taking a supplement containing ginger.
Ginkgo is a very popular supplement and is also available as a tea. “It can support brain health but should be avoided before and after surgery because of increased risk of bleeding,” says Tom. There are quite a few bioactive compounds in ginkgo, including kaempferol, quercetin, glycosides and ginkgolides. Its ginkgolides have been shown to adversely impact blood clotting and may promote bleeding.
Licorice root contains a compound called glycyrrhizin, which can cause irregular heartbeat and cardiac arrest if taken in large amounts. “In theory, licorice tea could raise blood pressure and cause surgery complications,” notes Tom.
Green tea is technically not an herbal tea, but it is a very popular tea and supplement. Reuben Chen, M.D., a physician and herbalist, notes that green tea’s catechins can increase the risk of bleeding. Green tea also interacts with some medications, including osteoporosis and cholesterol-lowering drugs.
Valerian root tea is commonly taken for sleep, although research on its effectiveness for promoting sleep or treating insomnia is inconclusive. Two of its constituents, valerinic acid and gamma-aminobutyric acid (GABA), may contribute to the sedative effects of the herb. Chen adds to avoid valerian after surgery, as its sedative effects can interact with narcotics. This may lead to excessive drowsiness and respiratory depression.
Chamomile tea is known for having an anticoagulant effect, notes Sung. It contains several bioactive compounds, especially coumarins, which may thin the blood. Right now, it’s unclear how much, if any, is safe. One recent small study found that drinking three cups of strong chamomile tea per day did not impact the time it took blood to clot. But it still makes sense to exercise caution. If you usually drink chamomile tea, check in with your health care professional to see if you should limit it around the time of your surgery.
Turmeric has been used for inflammation, pain and indigestion. Curcumin, perhaps the best-known active compound in turmeric, has anti-inflammatory properties. But it may also have antiplatelet effects. While research is still needed to determine if turmeric can cause post-operative bleeding, it couldn’t hurt to avoid it before and after surgery.
Before and after surgery, it’s natural to have a lot on your mind. But don’t forget to tell your health care provider about any herbal teas you usually drink. As innocent as herbal tea may seem, some herbal teas can cause dangerous complications if you drink them before or after surgery. “This revelation frequently arises during preoperative consultations, highlighting a common misconception that natural equates to safe,” says Chen. Herbal teas, like ginger, ginkgo biloba, licorice, valerian root, chamomile and turmeric tea, may lead to complications by interacting with medications or increasing bleeding risk or blood pressure. While it’s technically not an herbal tea, green tea may also act as a blood thinner.
Discussing your herbal intake with your health care team is important, as they can provide specific recommendations based on your health history and current supplement and medication routine. “The key is good communication with your surgeon and following their advice and instructions,” says Sung. Of course, not every surgery is planned in advance. Sung adds, “Herbal tea is not an absolute contraindication. If the surgery is urgent and necessary, it should proceed as long as the benefits outweigh the risks.”
XRP is showing signs of resilience as it holds $2 key support, sparking optimism among traders amid a volatile crypto market. Analysts are watching closely for potential rebounds.
The cryptocurrency has experienced notable swings in recent weeks, influenced by both market trends and regulatory developments. With Ripple’s recent initiatives and growing institutional interest, XRP may be positioned for a strong recovery toward the $5 mark.
XRP has recently stabilized near the $2 mark after a period of heightened volatility in the cryptocurrency market. Analysts and traders have noted that this level has acted as a strong horizontal support, preventing further declines and positioning the digital asset for a potential recovery. As of November 5, 2025, the XRP price today hovers around $2.22, following a rebound from its recent dip.
$XRP is expected to hold strong support around the $2 level. Source: Ali Martinez via X
Crypto analyst @ali_charts confirmed their October 31 prediction that XRP would find support at $2, a forecast that has now materialized. The chart from TradingView shows XRP’s daily price action on Binance, highlighting the $2 support level amid a broader downtrend from summer highs near $3.
“This support line has historically held during 20-30% corrections,” the analyst noted. “The current dip provides more clarity and may pave the way for a significant upside.”
In addition to technical support, Ripple XRP news highlights the launch of Ripple Prime, a new U.S.-focused crypto exchange that facilitates spot trading for institutional clients. The platform resulted from Ripple’s acquisition of Hidden Road and now enables over-the-counter (OTC) trading for large-scale investors.

Ripple Prime officially launches in the U.S., offering clients OTC spot trading for major digital assets and stablecoins, including $XRP and $RLUSD. Source: Ripple via X
Trading volumes on XRP have leaped, almost doubling to $8 billion—or about 6% of XRP’s circulating supply. Such liquidity may solidify xrp price prediction for 2025 by giving the token a basis to recover toward $5, some analysts say.
Although it has recently declined, technical indicators are showing a bullish scenario. XRP seems to form a bearish Bat harmonic pattern on the daily chart, hence a structure that normally forms in front of a potential reversal. The point C of this pattern, around $2.2285, has acted as a support, while the 200-day moving average, near $2.6235, is a key resistance.

The recent dip clarifies XRP’s weekly Elliott Wave pattern: Wave II is ending, and while a Wave 5 downside may form, it’s likely truncated and won’t break Wave 3’s low. Source: abdulahalkasid on TradingView
If XRP maintains its position above Point C and continues to gain momentum, it may move toward the potential reversal zone between $2.99 and $3.10. This setup indicates a near-term upside potential of approximately 34% from current levels, reinforcing the optimistic outlook for XRP price forecasts.
Analysts believe the price action of XRP will be determined by how the cryptocurrency behaves at its present support levels. If the token holds its current position above $2 and consolidates for a strong upward move, technical forecasts place the price closer to $5 in the next few months, backed by Elliott Wave patterns pointing toward the upside.

XRP was trading at around 2.25, down 1.13% in the last 24 hours at press time. Source: Brave New Coin
Failure to do so could mean a deeper pullback toward $1.60, though analysts consider this less probable given the prevailing market conditions. The neutral scenario is that XRP might consolidate between $2 and $2.50 before breaking out, establishing a very solid foundation for future gains. Analysts emphasize the importance of keeping a close eye on both technical indicators and macro market developments in light of ongoing regulatory updates that shape investor sentiment.
Other influences on XRP’s recent volatility have included regulatory updates, such as developments regarding the XRP SEC lawsuit. The resolution of some of these regulatory uncertainties has increased investor confidence and helped stabilize XRP.
This, combined with the possible approval of ETFs and continued institutional adoption, paints a bright outlook for XRP.
With XRP changing hands above the key support of $2 and growing institutional interest in the digital asset, the token seems well-positioned for a rally toward $5.
Market participants should continue to keep a close eye on the ongoing behavior of technical indicators, market sentiment, and regulatory developments that will materialize the price predictions of XRP for 2025.
Stream Finance, a decentralized finance (DeFi) protocol, has suspended all deposits and withdrawals after reportedly losing $93 million in an exploit involving one of its external asset managers. The company says it is assessing the full scope of the incident and has hired legal experts from Perkins Coie to investigate.
However, pending deposits will not be processed until further notice.
The issue began when Stream’s native stablecoin, Staked Stream USD (xUSD), lost its peg to the U.S. dollar. According to PeckShield, xUSD fell as low as $0.30 on Tuesday before partially recovering to the $0.37 range.
What’s with XRP?
This event quickly drew attention within the XRP community due to Stream’s connection with Midas, a platform that issues the mXRP liquid yield token on the XRP Ledger. Midas had previously held positions in xUSD through its mHYPER vault, which operates under MiCA-regulated structures in Germany.
While Midas claims to be operational and unaffected, traders have expressed concerns about indirect exposure through yield strategies tied to Stream’s assets.
Although the platform reiterated that withdrawals are functioning normally, several XRP community members described an atmosphere of “better safe than sorry” as users tested exit queues and liquidity buffers.
Looks like Midas was involved in the $93M loss of Stream earlier today. They claim they are unaffected.
Midas is known for also issuing mXRP on the XRP Ledger.
Word on the street recommends to withdraw. Better safe than sorry approach. pic.twitter.com/oD7XAWsI4t
Some advised users to withdraw from mHYPER as a precaution, citing potential clawback risks if legal action redistributes losses. Notable XRPL contributor Vet_X0 clarified that Midas’s exposure was limited to xUSD positions held days earlier and that normal redemption processing continues.
As of press time, the mXRP official dashboard shows a total value locked of about $25.55 million, with an advertised 10% annual yield.
Gold price rate today analysis, forecast and prediction indicate a steady recovery after recent declines. Spot gold rose 0.9% to $3,966.65 per ounce by 0713 GMT. The rise follows a fall of more than 1.5% on Tuesday when bullion touched its lowest level since October 30.
U.S. gold futures for December delivery increased by 0.4% to $3,975.30 per ounce. The U.S. dollar remained slightly below its three-month high recorded in the previous session.
According to Jigar Trivedi, senior currency analyst at Reliance Securities, the latest rise in gold prices reflects bargain buying and a general risk-off sentiment in global markets. This sentiment is supporting safe-haven demand for gold.
Asian stocks extended losses in early trading, following overnight declines on Wall Street. Investor concerns over stretched valuations continued to reduce confidence across markets.
Trivedi added that gold might face pressure if upcoming ADP data indicates stronger employment growth. A higher employment figure could reduce the likelihood of another rate cut this year. He also suggested that if the data exceeds expectations, gold could test levels near $3,900 per ounce.
The U.S. Federal Reserve recently cut interest rates. Fed Chair Jerome Powell suggested it might be the last rate reduction for this year. Following the announcement, the likelihood of another rate cut in December dropped from over 90% to around 69%, according to the CME FedWatch Tool. Officials at the Federal Reserve have shared mixed views on how to interpret current economic data, particularly as some U.S. government reports are delayed due to a potential government shutdown. The lack of new data is shifting investor attention to non-official sources, including the ADP National Employment Report expected later today.
Gold usually performs well when interest rates are low and economic uncertainty rises. The current market trend shows investors using gold as a hedge against potential risks and inflation concerns.
Despite today’s rise, gold remains below its recent record high of $4,381.21 reached on October 20. Since that peak, the metal has dropped by nearly 10%. Market participants remain cautious, balancing between expectations of further rate adjustments and signals from economic data releases.
Alongside gold, other precious metals also registered small gains. Spot silver increased by 1.1% to $47.61 per ounce. Platinum prices rose 0.4% to $1,541.17 per ounce. Palladium also moved higher by 0.5% to $1,398.28 per ounce.
Analysts note that these movements are linked to the broader recovery in commodity markets, as investors reposition portfolios amid shifting global financial conditions.
Based on the gold price rate today analysis, forecast and prediction, the near-term outlook for gold will depend on U.S. economic data, inflation expectations, and central bank policy signals. If inflation remains stable and employment data supports economic growth, gold may face downward pressure. However, if data reflects slowing growth or further policy easing, demand for gold could strengthen again.
Market experts continue to monitor the ADP report and upcoming Federal Reserve statements to gauge gold’s next direction. Until clarity emerges, price fluctuations are expected to remain within the current range.
Q2. What is the short-term outlook for gold price rate today analysis, forecast and prediction?
The short-term outlook depends on U.S. economic data and Federal Reserve policy. Prices may rise if economic growth slows or interest rate cuts continue.
slips as tech jitters overshadow stronger data. steadies post-BoJ minutes and ahead of .
The DAX, along with its European peers, is opening lower, extending losses for a second day. The negative start follows overnight deep declines in the US and Asia, as caution persists across global markets amid concerns about high valuations in AI-related and tech shares.
Valuation fears resurfaced this week on Wall Street after the record-breaking rally this year, driven by AI. However, warnings of a correction by the CEOs of major U.S. banks, Goldman Sachs, and Morgan Stanley, fueled concerns, accelerating the move lower.
Stronger-than-expected German data could help stem the sell-off. German factory orders rose 1.1% month on month in September, recovering from a 0.4% decline in August.
Meanwhile, the shows that activity in the service sector in October was stronger than expected, with output revised from the preliminary reading of 54.5 to 54.6. This marked the fastest growth in the sector in two years, supported by a notable increase in new business and contributing to the first rise in employment in the sector in 3 months. The , considered a good gauge of business activity, was also upwardly revised to 53.9. The level 50 separates expansion from contraction.
On the corporate front, Siemens Healthineer was the largest loser, dropping over 7% after posting Q4 revenue slightly below expectations, pressured by US tariff imports.
BMW is rising despite a decrease in earnings before tax to €2.3 billion, which contributed to a year-to-date figure of €8 billion. Vehicle deliveries rose by 8.7% year on year, with strong growth in Europe and the US.
After running into resistance at 24,635 in early August, the DAX has fallen further, breaking below the 50 SMA at 24,000 and spiking to a low of 23,580, which is the rising trendline support. The long lower wick suggests that there was little demand at the lower levels as dip buyers stepped in.
Buyers would need to rise above 24,000 to be on a more stable footing, bringing 24,400 into focus.
Sellers will need to break below yesterday’s low at 23580 and the rising trendline support. A break below here brings 23,400, the 200 SMA, and horizontal support into play.
USD/JPY is holding steady after yesterday’s losses, when the yen benefited from safe-haven flows amid the risk-off mood in the broader market.
However, today the picture has stabilised, suggesting that yesterday’s risk-off mood was more of a pause for breath rather than a decisive turning point.
Overnight, the minutes from the Bank of Japan meeting showed caution among board members due to the nation’s prolonged experience with deflation. The more dovish stance is limiting any upside in the yen.
While safe-haven plays have supported the yen, the also rose against its major peers yesterday on the same trade.
The US dollar trades at multi-month highs against its major peers, supported by declining bets on near-term Federal Reserve amid deep divisions among Federal Reserve board members.
Investors and policymakers are contending with a record-long government shutdown, which means U.S. economic data is scarce. As a result, more attention than usual will be on the private ADP payrolls later today, which is expected to show 25,000 jobs after -32k last month.
will also be in focus and as expected to rise to 50.8 up from 50 in September. Stronger data could help lift the US dollar, boosting USD/JPY.
USD/JPY trades in a rising channel. The price rose to an 8-month high of 154.50 in late October, hitting the upper bound of the rising channel before easing back to test 153.00, the October 9 high. The bullish trend is still intact. Buyers will look to rise above 154.50 to create a higher high, bringing 155 into focus ahead of 156.75.
Sellers will need to break below 153.00 to open the door to a deeper selloff towards 151.
usatoday.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use.
Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on usatoday.com
Gold (XAU/USD) is trading higher on Wednesday, supported by increasing demand for safe assets, with traders spooked by the sell-off in global equity markets. The precious metal bounced up from Tuesday’s lows in the area of $3,930 to session highs above $3,970 in the early European session, although it remains halfway through the last two weeks’ trading range.
Safe-haven assets remain buoyed on Wednesday following significant declines in the major Wall Street equity indices, which have spread through Asia and Europe. Concerns about an AI bubble resurfaced this week, as the CEOs from some of the US largest banks warned of a significant correction as geopolitical tensions increase.
The precious metal, however, remains trapped within previous ranges, as the hawkish tilt by Federal Reserve (Fed) Chairman Jerome Powell and the wide division among the central bank’s policymakers has prompted investors to reassess their bets for a December rate cut. This is providing support to US Treasury yields and the US Dollar, and keeping Gold’s recovery attempts limited so far.
In the US, the Government shutdown enters its fifth week, on track to become the largest in history, depriving the market and the Fed of key data to decide monetary policy. The release of the ADP Employment Change, thus, is likely to gain particular relevance later today. The market consensus anticipates a 25,000 increase on private payrolls in October, after a 32,000 decline in September, still at levels well below the nearly 150,000 new jobs averaged from 2010 to 2025.
Later on the day, the US ISM Services PMI is expected to show a mild recovery of the sector’s activity, with October’s reading increasing to 50.8 from the 50.0 level in September.
Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.
Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.
Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.
The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.
EUR/USD stages a rebound but remains slightly below 1.1500 in the European morning on Wednesday after closing the fifth consecutive day in negative territory and touching its weakest level since early August at 1.1473 on Tuesday. As market focus shifts to high-tier data releases from the US, the pair’s technical outlook shows no signs of a reversal.
The table below shows the percentage change of Euro (EUR) against listed major currencies this week. Euro was the weakest against the Japanese Yen.
| USD | EUR | GBP | JPY | CAD | AUD | NZD | CHF | |
|---|---|---|---|---|---|---|---|---|
| USD | 0.34% | 0.67% | -0.40% | 0.72% | 0.86% | 1.26% | 0.62% | |
| EUR | -0.34% | 0.34% | -0.67% | 0.39% | 0.50% | 0.92% | 0.28% | |
| GBP | -0.67% | -0.34% | -1.14% | 0.05% | 0.16% | 0.59% | -0.06% | |
| JPY | 0.40% | 0.67% | 1.14% | 1.10% | 1.24% | 1.65% | 1.15% | |
| CAD | -0.72% | -0.39% | -0.05% | -1.10% | 0.07% | 0.50% | -0.10% | |
| AUD | -0.86% | -0.50% | -0.16% | -1.24% | -0.07% | 0.42% | -0.20% | |
| NZD | -1.26% | -0.92% | -0.59% | -1.65% | -0.50% | -0.42% | -0.64% | |
| CHF | -0.62% | -0.28% | 0.06% | -1.15% | 0.10% | 0.20% | 0.64% |
The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Euro from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent EUR (base)/USD (quote).
The risk-averse market atmosphere, as reflected by the sharp decline seen in Wall Street’s main indexes, helped the US Dollar (USD) preserve its strength on Tuesday and caused EUR/USD to continue to push lower.
In the European morning on Wednesday, US stock index futures trade mixed and highlight a cautious market stance, which is likely to cap EUR/USD’s recovery attempts.
In the second half of the day, ADP Employment Change and the Institute for Supply Management’s (ISM) Services Purchasing Managers’ Index (PMI) data for October will be featured in the US economic calendar.
Investors expect employment in the private sector to rise by 25,000 following the 32,000 decline recorded in September. A positive surprise, with a reading of 50,000, or higher, could boost the USD with the immediate reaction and open the door for a leg lower in EUR/USD. On the flip side, investors could lean toward a Fed rate cut in December if the ADP data comes in weaker than forecast. According to the CME FedWatch Tool, markets are currently pricing in about a 70% probability of a 25 basis points (bps) rate cut in December.
Market participants will also pay close attention to the underlying details of the ISM Services PMI report. If the headline PMI comes in above 50, as expected, and there is a noticeable increase in the Employment Index of the survey, the USD is likely to gather strength. Conversely, a disappointing headline PMI print in the contraction territory below 50 and a lack of improvement in the employment component could hurt the USD and help EUR/USD hold its ground.
EUR/USD remains in the lower half of the descending regression channel and the Relative Strength Index (RSI) indicator sits below 40, suggesting that EUR/USD has more room on the downside before turning technically oversold.
Looking south, the first support level could be spotted at 1.1450 (lower limit of the descending channel, static level) before 1.1400 (static level) and 1.1370 (static level). On the upside, resistance levels could be seen at 1.1500 (former support), 1.1550 (static level) and 1.1580 (50-period Simple Moving Average).
The Euro is the currency for the 20 European Union countries that belong to the Eurozone. It is the second most heavily traded currency in the world behind the US Dollar. In 2022, it accounted for 31% of all foreign exchange transactions, with an average daily turnover of over $2.2 trillion a day.
EUR/USD is the most heavily traded currency pair in the world, accounting for an estimated 30% off all transactions, followed by EUR/JPY (4%), EUR/GBP (3%) and EUR/AUD (2%).
The European Central Bank (ECB) in Frankfurt, Germany, is the reserve bank for the Eurozone. The ECB sets interest rates and manages monetary policy.
The ECB’s primary mandate is to maintain price stability, which means either controlling inflation or stimulating growth. Its primary tool is the raising or lowering of interest rates. Relatively high interest rates – or the expectation of higher rates – will usually benefit the Euro and vice versa.
The ECB Governing Council makes monetary policy decisions at meetings held eight times a year. Decisions are made by heads of the Eurozone national banks and six permanent members, including the President of the ECB, Christine Lagarde.
Eurozone inflation data, measured by the Harmonized Index of Consumer Prices (HICP), is an important econometric for the Euro. If inflation rises more than expected, especially if above the ECB’s 2% target, it obliges the ECB to raise interest rates to bring it back under control.
Relatively high interest rates compared to its counterparts will usually benefit the Euro, as it makes the region more attractive as a place for global investors to park their money.
Data releases gauge the health of the economy and can impact on the Euro. Indicators such as GDP, Manufacturing and Services PMIs, employment, and consumer sentiment surveys can all influence the direction of the single currency.
A strong economy is good for the Euro. Not only does it attract more foreign investment but it may encourage the ECB to put up interest rates, which will directly strengthen the Euro. Otherwise, if economic data is weak, the Euro is likely to fall.
Economic data for the four largest economies in the euro area (Germany, France, Italy and Spain) are especially significant, as they account for 75% of the Eurozone’s economy.
Another significant data release for the Euro is the Trade Balance. This indicator measures the difference between what a country earns from its exports and what it spends on imports over a given period.
If a country produces highly sought after exports then its currency will gain in value purely from the extra demand created from foreign buyers seeking to purchase these goods. Therefore, a positive net Trade Balance strengthens a currency and vice versa for a negative balance.
Despite the importance of quality prenatal care, a relatively small percentage of mothers or fathers invest in their health and well-being before becoming pregnant. This cross-sectional study, which included 445 mothers, aimed to investigate the impact or association of various maternal and paternal factors on infant health. This study revealed that around 145 (32.6%) of infants had disease; according to the ICD-10, the most common diseases in descending order were malnutrition, followed by diseases that occurred within the first month after birth, congenital defects, other unspecified conditions, and then chronic respiratory and cardiovascular. This study highlights the importance of socioeconomic factors, healthy parental lifestyle, preconception, antenatal, and antenatal care, in improving infant health outcomes.
The average maternal and paternal ages were 27.72 ± 6.35 and 32.35 ± 7.25 years, respectively. Most mothers were Palestinian (34.8%), Egyptian (26.7%), or Yemeni (15.7%). Residency was predominantly urban (62.7%), while 37.3% lived in rural areas. Income levels varied, with 69% reporting their income as”enough,”16% as”more than enough,”and 23% as”not enough.”These findings align with those of Alfayez et al. [33], who examined Saudi women’s attitudes toward newborn screening programs.
Maternal nationality showed a significant association with infant health, with Palestinian mothers reporting higher rates of poor infant health, potentially reflecting disparities in healthcare access and socioeconomic conditions. Lower income levels were also strongly correlated with adverse child health outcomes [34], as 55.2% of parents covered medical expenses out of pocket. These findings highlight the role of financial stability in infant health and the need for supportive policies.
Parental substance use, including smoking (P = 0.042), cannabis (P = 0.006), and alcohol consumption (P = 0.003), significantly impacted child health. Maternal smoking during pregnancy is a well-documented risk factor for miscarriage, low birth weight, prematurity, and perinatal mortality [35,36,37,38,39], emphasizing the need for public health interventions.
Chronic parental illnesses, such as diabetes and hypertension, were also linked to poorer infant health [45], likely due to their impact on caregiving and overall family well-being [46]. Conversely, factors such as residence, smoking cessation, hookah use, addiction status, immune and neuropsychiatric conditions, and family history of cancer showed no significant association with infant health, possibly due to confounding variables.
A majority of mothers (71.0%) had no prior smoking history, indicating a predominantly non-smoking population. Former smoking was reported by 8.5% of mothers and 16.2% of fathers, with higher cessation rates among fathers. Current smoking showed a pronounced gender disparity, with 1.8% of mothers and 40.2% of fathers actively smoking, consistent with global trends of higher male smoking prevalence, particularly in certain cultural contexts.
Addiction-related issues were minimal, with 96.9% of mothers reporting no substance dependence. Cultural perceptions and question phrasing may have influenced responses, particularly regarding non-substance-related behaviors.
Chronic diseases were reported in 6.7% of mothers and 18.4% of fathers, suggesting potential lifestyle influences on health. Biological, cultural, and socioeconomic factors may contribute to the observed gender disparity. Immune-related conditions, including multiple sclerosis, lupus, and rheumatoid arthritis, were reported by 2.0% of participants, potentially reflecting regional variations in incidence. Neuropsychiatric disorders were also low (2.0%), possibly due to underreporting, lack of diagnosis, or cultural stigma.
A family history of cancer was noted in 7.6% of participants, with maternal history (3.4%) being more prevalent than paternal history (1.1%), suggesting potential hereditary risks. Additionally, 4.0% reported the same type of tumor within their family, while 2.2% had a personal history of tumors. Despite genetic predispositions, 96.0% remained cancer-free, highlighting the potential role of environmental and protective factors in mitigating risk.
The consumption of milk and dairy products was significantly associated with reduced infant disease prevalence (P = 0.014). Dairy products provide essential nutrients, including calcium, vitamin D, and protein, which support fetal bone and nervous system development [42, 43]. However, the study found no significant associations for other dietary groups like cereals, bread, fruits, vegetables, or water intake, indicating that these foods may have a less direct impact on infant health.
The most consumed supplements were in descending order: folic acid (75%), iron (72%), calcium (64%), and vitamin D (53.3%), with no significant associations with the frequency of infant disease. They used these supplements for preventative and medicinal immunological enhancement to promote the health of both infants and mothers. The price, accessibility, and acceptability of dietary supplements may account for the significant variations in usage frequency across different studies [40].
Regarding the consumption of diet or sugar-free beverages containing aspartame, 13.3% of participants reported consuming these drinks, while 71.9% indicated they did not. The limited consumption of aspartame-sweetened beverages suggests a preference for traditional sugary drinks or a shift toward natural sweeteners due to taste preferences, health consciousness, or emerging trends favoring healthier alternatives.
The results suggest that high-risk pregnancies identified by medical professionals are associated with increased child morbidity as Mothers who received a doctor’s warning during pregnancy reported a significantly higher incidence of infant diseases (66.6% vs. 31.6%, P = 0.02). Similarly, folic acid deficiency before or during early pregnancy was significantly associated with child disease (P = 0.003), highlighting the protective role of folic acid in preventing neural tube defects and other congenital abnormalities [32, 42].
A delayed awareness of pregnancy was also linked to higher infant disease risk (16.6%, P = 0.04), possibly due to postponed prenatal care or lifestyle adjustments. Non-prescription drug use during pregnancy was another significant factor (P = 0.008), emphasizing the need for healthcare professionals to educate pregnant women on the safe use of medications. Routine prenatal visits were associated with improved infant health outcomes (P = 0.03), reinforcing the importance of consistent antenatal care in reducing neonatal mortality and promoting maternal and infant health [33, 41, 44].
Pregnancy-related hyperemesis (P = 0.030) and chronic infections (P < 0.00005) were significantly associated with increased infant illness. Hyperemesis can lead to maternal malnutrition and dehydration, affecting fetal development, while chronic infections may involve direct pathogen transmission or immunological responses [45]. Mode of delivery also played a role, with cesarean sections associated with poorer infant health outcomes (P < 0.05), potentially due to complications such as delayed breastfeeding or neonatal respiratory issues.
Admission to neonatal intensive care units (NICUs) was strongly associated with infant disease (P < 0.00002), as premature birth or underlying health conditions often necessitate incubation. Low birth weight, delayed motor development, and impaired social or mental development significantly correlated with child illness, with P -values ranging from 0.00002 to 0.00000001.
Exposure to COVID-19 during pregnancy showed a significant association with higher infant illness frequency (P = 0.05). The results indicate a significant association between SARS-CoV-2 exposure during pregnancy and infant disease (P = 0.05), suggesting that maternal infection during pregnancy may pose risks to infant health. parents who were not vaccinated had a higher prevalence of infant disease (P = 0.02). These findings underscore the relevance of both parental COVID-19 exposure and vaccination status in influencing infant health. Potential mechanisms include maternal inflammation, fever, or vertical transmission of the virus, all of which could impact fetal development. In agreement with other studies [46, 47]. Further research is guaranteed to understand these relationships fully.
This study has many strengths, including a multi-national, targeted, relatively large sample of mothers from four low- to middle-income countries (Egypt, Jordan, Yemen, and Palestine). Researchers are increasingly focusing on identifying maternal risk factors associated with adverse birth outcomes. The impact of paternal factors on birth outcomes has received significantly less attention. This study is one of the few studies to examine the influence of multiple parental factors, including paternal lifestyle factors, SARS-CoV-2 virus exposure, and COVID-19 vaccination on infant health.
Moreover, this study also had many limitations, e.g., the cross-sectional design prevents establishing causality, and reliance on self-reported data introduces recall bias. Mothers reported paternal factors rather than fathers explicitly, which is particularly concerning. One of the limitations is that there are significant variations in the sample size collected from different nationalities; for example, Palestinian mothers constituted the largest group, followed by Egyptian and Yemeni mothers. The variability may be attributed to the flow rate in the selected primary care centers, in addition to the long waiting time that facilitates face-to-face interviews for data collection. Furthermore, the findings may not be generalized beyond the study’s specific cultural and geographical context and include only mothers who meet the specified inclusion and exclusion criteria attending PHCCs. Although we selected investigators or researchers to collect data from their institutions or nearby PHCCs e.g. Ahmed A. Amer, Mohamed SH. Ramadan, Mahmoud T. Hefnawy and Hanaa S. Said from Egypt; Hamza A. Abdul-Hafez from Palestine; Batool Turki Gharaibeh from Jordan; and Muna Ali Mugibel from Yemen. They chose a random sample of mothers who meet the selection criteria from the accessible or nearby PHCCs, but this study cannot be called population based.
The findings of this study emphasize the critical need for integrating comprehensive maternal and paternal health assessments into routine antenatal care. By identifying and addressing modifiable risk factors such as smoking, improper folic acid intake, and chronic infections early in pregnancy, healthcare providers can significantly reduce adverse infant health outcomes. Additionally, the study underscores the importance of prioritizing maternal COVID-19 vaccination as a preventive measure during pregnancy. Clinicians should adopt a holistic approach that includes dietary counseling, stress management support, and guidance on safe medication used to optimize maternal health and, by extension, infant well-being. These insights call for the incorporation of targeted education and screening protocols in clinical settings to mitigate preventable risks and enhance neonatal health outcomes.